Gaithersburg’s Novavax has struck a deal to give Pfizer the rights to its adjuvant technology — for a potential $530 million ...
By Michael Erman and Christy Santhosh Jan 20 (Reuters) - Novavax said on Tuesday it signed a licensing agreement allowing ...
Maryland-based Novavax signed a licensing agreement allowing Pfizer access to its technology that boosts immune responses to ...
Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.
Zacks Investment Research on MSN
Novavax grants license for use of Matrix-M adjuvant to Pfizer
Novavax NVAX announced a non-exclusive license agreement with Pfizer PFE, granting the latter access to its proprietary ...
Novavax said on Tuesday it was entering into a licensing agreement with Pfizer to develop vaccine products for ...
The US Department of Health and Human Services is recommending fewer vaccines for most American children, health officials said Monday. Health officials will continue to recommend the measles, mumps ...
One third of adults disapprove of the Trump administration’s decision to remove Nicolás Maduro from the presidency of Venezuela, according to a Reuters/Ipsos poll released Jan. 5. But one third of ...
In 2025, federal health agencies dismantled precedents in vaccine guidance, fracturing state-federal alignment and fueling concerns about public health guidance. HHS Secretary Robert F. Kennedy Jr.
It comes as the U.S. surpassed 2,000 measles cases for the 1st time in 33 years. Children who miss early vaccinations are far more likely to miss the measles, mumps, rubella (MMR) vaccine by age 2, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results